KBRA Releases Research – Structured Credit Trend Watch: Volume Amid Volatility
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases a report examining trends across the structured credit landscape, including issuance,…
Month: October 2022
University of Phoenix Announces Agreement With Northwest Career College to Help Students Affordably Earn Degrees
Academic agreement supports transfer pathway for students from community college to higher degrees exclusively at…
KBRA Releases RMBS Credit Indices (KCI) for September 2022
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases its RMBS Credit Indices (KCI) for September 2022. The indices track…
KBRA Releases Research – Private Credit: Well Positioned to Navigate the Looming Storm
NEW YORK–(BUSINESS WIRE)–#KBRA–KBRA releases research that examines the $1.2 trillion private credit industry, which is…
Wolters Kluwer ELM Solutions’ 2022 Real Rate Report indicates that timekeeper rates continue to rise
The report uses legal invoice data to provide law firm rate benchmarks and enable more…
EA SPORTS™ NHL® 23 Introduces Women’s Players to Ultimate Team and Makes Players Greater Together, Now Available Worldwide
Deep Franchise Mode Options, Cross-Platform Matchmaking and Social Features Enhance the Most Customizable Hockey Experience…
#GoToGetsIT: Putting the human back into IT
Your computer starts malfunctioning, and you have no idea what’s wrong – what’s an employee…
BMF-219 Enters the Clinic for KRAS Solid Tumors
Biomea Fusion announces FDA clearance of Investigational New Drug (IND) application for covalent menin inhibitor…
Salarius Pharmaceuticals Announces 1-for-25 Reverse Stock Split
HOUSTON, Oct. 14, 2022 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (NASDAQ: SLRX), a clinical-stage biopharmaceutical…
Biofrontera Inc. Adopts Limited Duration Shareholder Rights Plan
WOBURN, Mass., Oct. 14, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a…
Novo Nordisk announces the completion of the Forma Therapeutics acquisition
Bagsværd, Denmark, 14 October 2022 – Novo Nordisk today announced that the acquisition of Forma…
Novan and EPI Health, a Novan Company, Announce Abstracts Accepted for Poster Presentation at the 42nd Annual Fall Clinical Dermatology Conference®
DURHAM, N.C., Oct. 14, 2022 (GLOBE NEWSWIRE) — Novan, Inc. (“the Company” or “Novan”) (Nasdaq:…
T2 Biosystems Highlights Multiple New Studies Demonstrating Improved Rapid Detection Across Several Patient Populations
Studies demonstrate that T2Bacteria and T2Candida panels enable sensitive and specific diagnosis to enhance the…
Chinook Therapeutics Announces Upcoming Presentations and Investor Conference Call at the American Society of Nephrology (ASN) Kidney Week 2022
Updated interim data to be presented from the IgA nephropathy (IgAN) patient cohort of the…
Aligos Therapeutics Initiates Dosing In Healthy Volunteers With siRNA Drug Candidate ALG-125755
Single ascending doses to be evaluated in healthy volunteers in Q4 2022 Single ascending doses…
Verano Repudiates Transaction to Acquire Goodness Growth Holdings
MINNEAPOLIS, Minn. and VANCOUVER, British Columbia, Oct. 14, 2022 (GLOBE NEWSWIRE) — Goodness Growth Holdings,…
Bavarian Nordic Enters Agreement with Switzerland on the Supply of Smallpox and Monkeypox Vaccine
Switzerland has ordered 100,000 doses of smallpox and monkeypox vaccine with deliveries starting imminently Bavarian…
Enzo Biochem Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update
– Enzo Life Sciences reports revenue of $32.6 million and 8% growth in FY 2022,…
BridgeBio Pharma Presents 12-month Results from Phase 2 Study of BBP-418 in Limb-Girdle Muscular Dystrophy Type 2i (LGMD2i)
Novel assay developed to assess the extent of alpha-dystroglycan (⍺DG) glycosylation, the core pathology of…
Novartis receives positive CHMP opinion for Pluvicto® for patients with progressive, PSMA-positive metastatic castration-resistant prostate cancer
Phase III VISION trial showed Pluvicto® plus best standard of care significantly improved survival for…